Lubiprostone in chronic kidney disease: Insights into mitochondrial function and polyamines from a randomized phase 2 clinical trial.
Watanabe S, Nakayama M, Yokoo T, Sanada S, Ubara Y, Komatsuda A, Asanuma K, Suzuki Y, Konta T, Kazama JJ, Suzuki T, Fukuda S, Soga T, Yamada T, Mizutani S, Matsumoto M, Naito Y, Taguchi K, Fukami K, Kashiwagi H, Kikuchi K, Suzuki C, Tokuno H, Urasato M, Kujirai R, Matsumoto Y, Akiyama Y, Tomioka Y, Itai S, Tongu Y, Mishima E, Kawabe C, Kasahara T, Ogata Y, Toyohara T, Sato T, Tanaka T, Abe T; LUBI-CKD TRIAL Investigators.
Watanabe S, et al. Among authors: abe t.
Sci Adv. 2025 Aug 29;11(35):eadw3934. doi: 10.1126/sciadv.adw3934. Epub 2025 Aug 29.
Sci Adv. 2025.
PMID: 40880481
Free PMC article.
Clinical Trial.